Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu and currently employs 5,769 full-time employees. The company went IPO on 2015-12-30. The firm operates through four segments. The Life-Science Services and Products segment provides comprehensive reagent services and products, instruments and custom-tailored solutions for gene therapy, cell therapy, antibody therapeutics, vaccines and diagnostics. The Biologics Development Services segment provides comprehensive services aimed to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production by non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment is engaged in the discovery and development of novel cell therapies for oncology and other indications.
Follow-Up Questions
GNNSF 股票的價格表現如何?
GNNSF 的當前價格為 $2.15,在上個交易日 decreased 了 0%。
Genscript Biotech Corp 的主要業務主題或行業是什麼?
Genscript Biotech Corp 屬於 Life Sciences Tools & Services 行業,該板塊是 Health Care